Partner Headlines - ILMN

  1. Week In Review: Suzhou's Innovent Biologics Announces Record ...

    TalkMarkets
  2. OraSure Stock Sets Up For Buy Point On Hep C Contract, Helix ...

    Investors Business Daily
  3. Market Reversal In Biotech But Healthcare Stocks Are Still Muddled ...

    TalkMarkets
  4. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets
  5. 5 Healthcare Stocks To Buy Despite A Clinton Victory

    TalkMarkets
  6. Biotechnology Bear Market: Trends To Watch For A 2016 Q4 Rally

    TalkMarkets
  7. Illumina Misses Revenue Forecast Causing Collateral Damage To ...

    TalkMarkets
  8. Illumina Plunges After Cutting Estimated Q3 Revenue View

    TalkMarkets
  9. Top Stock Stories At Midday: Oct. 11

    TalkMarkets
  10. 5 Large Caps For Momentum Investors - October 3, 2016

    TalkMarkets
  11. Rayno 2016 Life Science Portfolio Update

    TalkMarkets
  12. 5 Great Nasdaq 100 Stocks For Momentum Investors

    TalkMarkets
  13. Biotech ETFs Lead Q3 Rally: XBI Breaks Out

    TalkMarkets
  14. Baron Funds Comments on Illumina Inc.

    GuruFocus
  15. Biotech Stocks Slip As Hugely Popular Momentum ETF Makes A Big ...

    IBD
  16. Stocks Open Down, Reverse Higher; Prestige, Nike, Fastenal Soar

    IBD
  17. Benzinga's Top Downgrades

    Benzinga
  18. Stock Indexes Trade Mixed, But Medicals Fall; Illumina Hits Low

    IBD
  19. Illumina Brings More Pain To Battered Biotech ETFs; Gold Hits ...

    IBD
  20. Illumina Names Dr. Frances Arnold to Board of Directors

    Benzinga
  21. Juno Buyout Puts Single-Cell Sequencing In Spotlight

    IBD
  22. Walgreens Exec Buys, CVS CEO Sells Amid Market Rout

    IBD
  23. Celgene, Vertex, Illumina Offer Mixed Outlooks

    IBD
  24. Illumina Forms GRAIL to Enable Early Cancer Detection via Blood-Based ...

    Benzinga
  25. Apple Supplier Avago A Top Pick; BlackBerry PT Hiked

    IBD
  26. Should You Wait to Bet on Agilent Technologies?

    GuruFocus
  27. Steve Mandel Acquires Stakes in Amazon.com and Constellation ...

    GuruFocus
  28. Desktop Genetics Receives Strategic Investment from Illumina

    Benzinga
  29. John Griffin Buys Autodesk, Apple, Sells AIG, Fitbit

    GuruFocus
  30. Julian Robertson Keeps Buying Citigroup, Netflix, Facebook

    GuruFocus
  31. Frank Sands Invests in Stake in Amazon.com

    GuruFocus
  32. Facebook, Apple, Gilead Honchos Lead Insider Deals

    IBD
  33. Benzinga's Volume Movers

    Benzinga
  34. Morning Market Gainers

    Benzinga
  35. Benzinga's Top #PreMarket Gainers

    Benzinga
  36. Don't Allow A Healthy Winner To Turn Into A Loser

    IBD
  37. Baron Funds Comments on Illumina Inc.

    GuruFocus
  38. Stocks Slip, Retake Slim Gains; Monster, Bank Of The Ozarks Rise

    IBD
  39. Benzinga's Top Downgrades

    Benzinga
  40. Nasdaq, S&P 500 End Win Streaks; Autobytel Gains

    IBD
  41. DuPont Cushions Dow; Chip Stocks, Biotechs Weigh On Nasdaq

    IBD
  42. Stocks Wrestle In Mixed Action; DuPont Surges, Illumina Dives

    IBD
  43. Morning Market Losers

    Benzinga
  44. Benzinga's Top Downgrades

    Benzinga
  45. Stock Futures Down, Off Lows On News From DuPont, Pepsi, Illumina

    IBD
  46. Illumina Downgraded; Apple Supplier Skyworks PT Cut

    IBD
  47. Benzinga's Top #PreMarket Losers

    Benzinga
  48. Illumina Plunges On Outlook

    IBD
  49. Stock Leadership Has Dumped Medical, Turned Diverse

    IBD
  50. Illumina Stock Dives On Latest Sales Warning

    IBD
  51. Genomics Out Of 'Caveman Era,' But Still A Ways To Go

    IBD
  52. Gilead, Valeant Downgraded; IBM, Dunkin' PTs Cut

    IBD
  53. Stocks End Narrowly Mixed Ahead Of Job Report

    IBD
  54. Illumina Tumbles On Downgrade, New Competition

    IBD
  55. Apple Supplier Skyworks Is A Buy; Celgene Upgraded

    IBD
  56. Stocks Move Lower; Slow Sales Take Bite Out Of Dunkin' Brands

    IBD
  57. Stocks Give Up Early Gains As Apple, Illumina, Sucampo Slide

    IBD
  58. Morning Market Losers

    Benzinga
  59. Benzinga's Top Downgrades

    Benzinga
  60. Apple Supplier Skyworks Is A Buy; Celgene Upgraded

    IBD
  61. Benzinga's Top #PreMarket Losers

    Benzinga
  62. Netflix, Google CEOs Top This Week's Insider Sales

    IBD
  63. BioMed Realty Trust REIT Looks For A Buyer

    IBD
  64. Amgen And Biogen Lead Short Interest Surge In Biotechs

    Benzinga
  65. Frank Sands Shows Bold Side in Second-Quarter Trades

    GuruFocus
  66. Perigon Wealth Management's Largest Buys in Second Quarter

    GuruFocus
  67. Benzinga's Top Initiations

    Benzinga
  68. Burning Rock, Illumina Announce Collaboration on Molecular Diagnostics ...

    Benzinga
  69. Baron Funds Comments on Illumina Inc.

    GuruFocus
  70. Baron Funds Comments on Illumina Inc.

    GuruFocus
  71. Illumina, Warburg Pincus, Sutter Hill Ventures Form Helix With ...

    Benzinga
  72. Good Stocks Differ, So Know What You're Looking At

    IBD
  73. Big Cap Leaders Sail Past Earnings Season

    IBD
  74. 4 IBD 50 Stocks Poised To Bounce Back With Market

    IBD
  75. Valeant, Starbucks Lead 5 IBD 50 Stocks Bucking Market

    IBD
  76. Bruised Apple Batters Stocks

    IBD
  77. Illumina Breaches Key Level On Q2 Sales Miss

    IBD
  78. Comeback Efforts Lose Steam; Lithia Revs Higher

    IBD
  79. Morning Market Losers

    Benzinga
  80. Stock Futures Down, Action Mixed; Apple, Vasco, Illumina Tumble

    IBD
  81. Benzinga's Top #PreMarket Losers

    Benzinga
  82. Illumina Disappoints On Sales

    IBD
  83. GoPro, Fitbit Surge As Indexes Dip; Apple Down Late

    IBD
  84. Illumina Stock Dives As Q2 Earnings Beat, Sales Miss

    IBD
  85. Stock Futures Mixed, IBM Weighs; Infosys, Tesla, Apple In Motion

    IBD
  86. Earnings Loom For Handful Of Top Big Cap 20 Stocks

    IBD
  87. Move Aside Apple: 8 IBD 50 Stocks With Earnings Due

    IBD
  88. Newfound Market Strength Could Benefit These IBD 50 Names

    IBD
  89. Google Rally Masks Weakness; Domino's Falls, SolarWinds Crushed

    IBD
  90. As Biotech Beats, 6 Top ETF Picks For Rest Of 2015

    IBD
  91. Big Cap 20: Biotech Red-Hot As Medicals Stay Dominant

    IBD
  92. Top Mutual Funds Add Abiomed, Tech Stocks And Monster

    IBD
  93. Big Cap 20: Does Edwards Lifesciences Have More Left?

    IBD
  94. 5 IBD 50 Stocks Hold Tight After Monday's Plunge

    IBD
  95. Big Cap Leaders Slide As Much As 4.7%

    IBD
  96. How Will Internet Of Things Change Health Care?

    IBD
  97. Internet ready to go to health

    IBD
  98. Internet Of Things Coming To U.S. Health Care

    IBD
  99. For The Record

    IBD
  100. Illumina, A Gene Research Leader, In Buy Range

    IBD
Trading Center